F
FluidAI
Developing an implantable biochip to detect post-operative complications
About FluidAI
FluidAI, formerly known as NERv Technology, is a Canadian medical technology company that has developed an AI-powered platform for the early detection and monitoring of postoperative complications, specifically leaks after general and abdominal surgeries. The company's core product, the Stream™ Platform, is a non-invasive system that continuously analyzes wound fluid from existing catheters to identify potential issues before they become critical. This allows for timely intervention, which can significantly improve patient outcomes and reduce the length and cost of hospital stays.
FluidAI's business model is centered on providing its advanced sensing technology and AI-enabled insights to hospitals and healthcare providers. The company collaborates with healthcare institutions, such as the Mayo Clinic, to further develop and validate its AI-driven solutions. By integrating with existing medical devices and workflows, FluidAI aims to streamline hospital operations and establish a new standard of postoperative care. The company serves the global healthcare market, with a focus on surgical departments and intensive care units.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Waterloo, Canada
- Employees
- 58
- Open positions
- None listed
- Dealroom signal
- 58.1/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Risk Management, Surgery, Health Diagnostics, Hospital, Hard Tech, remote health monitoring, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Oct 2023 | $15M | $60M | Threshold Impact · Juno Pharmaceuticals Canada · Boutique Venture Partners · SOSV | ↗ |
| SEEDEquity / VC | Jun 2022 | $0 | — | SOSV | — |
Growth signals
Latest recorded traffic for FluidAI is 210 monthly website visits, down 22.2% over the last three months. FluidAI's team declined 3.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed10 investors entered at this stage
Accelerator Centre
Ontario Centre of Innovation
Government of Canada
SOSV
Hax
Graphene Ventures
NorthSpring Capital Partners
Boutique Venture Partners
Threshold Impact
Center of Aging and Brain Health Innovation
Series A5 investors entered at this stage
Dorm Room Fund
Juno Pharmaceuticals Canada- KSKYTO Technology & Life Science
Leva Capital
Cur8 Capital
Other known investors6 additional known investors
Creative Destruction Lab
Juno Pharmaceuticals
L-SPARK
Natural Sciences and Engineering Research Council of Canada (NSERC)- SCSunhope Capital
Velocity
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about FluidAI on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See FluidAI’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.